{
  "meta": {
    "title": "Contrast_Agents",
    "url": "https://brainandscalpel.vercel.app/contrast-agents-e9995723.html",
    "scrapedAt": "2025-11-30T11:20:32.504Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased creatinine levels</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased blood urea nitrogen (BUN)</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased serum potassium</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">New onset proteinuria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the primary diagnostic indicator for contrast-induced nephropathy (CIN)?</span></p>",
      "unique_key": "DT1282923",
      "question_audio": null,
      "question_video": null,
      "map_id": 1282923,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p><strong>Increased creatinine levels</strong> are the primary and most established diagnostic indicator of contrast-induced nephropathy (CIN). CIN refers to an acute kidney injury that occurs after the administration of iodinated contrast media. Its pathogenesis involves a combination of renal vasoconstriction leading to medullary hypoxia, direct tubular toxicity from the contrast agent, and oxidative stress.</p>\n<ul>\n<li><strong>Definition:</strong> Contrast-induced nephropathy (CIN) is defined as an increase in serum creatinine by more than 25% from baseline or an absolute increase of more than 0.5 mg/dL within 48&ndash;72 hours of intravenous (IV) contrast exposure. A related term, <strong>post-contrast acute kidney injury (AKI)</strong>, refers to a rise in serum creatinine by more than 0.3 mg/dL within 48 hours of contrast administration.</li>\n<li><strong>Risk Factors:</strong> Major risk factors for CIN include decreased eGFR (&lt;60 mL/min for intra-arterial and &lt;45 mL/min for IV contrast), diabetic nephropathy, myeloma kidney, dehydration, congestive heart failure, hypertension, recent myocardial infarction, elderly age, low hematocrit, and high contrast volume. The use of intra-arterial injections and high-osmolar ionic contrast media further increases risk.</li>\n<li><strong>Biomarkers:</strong>Early biomarkers for CIN include serum neutrophil gelatinase-associated lipocalin (NGAL), serum cystatin C, interleukin-18, kidney injury molecule-1 (KIM-1), and beta-2 microglobulin (&beta;2M). A decrease in eGFR is considered a more reliable indicator of risk than serum creatinine levels alone.</li>\n<li><strong>Prevention:</strong> The single best step in preventing CIN is <strong>adequate IV hydration</strong>, which improves renal perfusion and reduces tubular toxicity. Pre-procedural assessment of renal function is particularly important in elderly and diabetic patients. Other agents like N-acetylcysteine (NAC), ascorbic acid, and sodium bicarbonate have been investigated, but none are superior to hydration in terms of efficacy.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Increased blood urea nitrogen (BUN) (Option B):</strong> While BUN often rises concurrently with creatinine in acute kidney injury, it is less specific than creatinine. BUN levels can be influenced by other factors such as dehydration, gastrointestinal bleeding, or high protein intake, making it a less reliable primary diagnostic marker for CIN compared to creatinine.</p>\n<p><strong>Increased serum potassium (Option C):</strong> Hyperkalemia (increased serum potassium) is a serious <em>complication</em> that can occur in patients with severe acute kidney injury, including CIN, due to impaired renal excretion. However, it is a consequence of kidney failure, not the initial diagnostic criterion for CIN itself.</p>\n<p><strong>New onset proteinuria (Option D):</strong>Proteinuria (protein in the urine) indicates kidney damage, but it is not the acute diagnostic marker for CIN. It is more commonly associated with chronic kidney disease, glomerular diseases, or other specific forms of acute kidney injury, rather than the rapid onset definition of CIN based on creatinine changes.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Contrast-Induced Nephropathy (CIN) is acute kidney injury following contrast media. The <strong>primary diagnostic indicator for CIN is an increase in serum creatinine levels</strong>, defined by specific criteria. Key <strong>risk factors</strong> include pre-existing kidney disease and diabetes.</p>",
      "correct_choice_id": 1,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Iodine</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Gadolinium</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">DTPA</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">SF6</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Nephrogenic systemic fibrosis develops as a toxicity to?</span></p>",
      "unique_key": "DT1282925",
      "question_audio": null,
      "question_video": null,
      "map_id": 1282925,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p><strong>Gadolinium</strong> is the substance to which nephrogenic systemic fibrosis (NSF) develops as a toxicity.</p>\n<ul>\n<li>Gadolinium is the most commonly used <strong>MRI contrast agent</strong>. It is a paramagnetic, intravascular extracellular compound with <strong>atomic number 64</strong>, and primarily produces <strong>T1 shortening</strong>, resulting in <strong>positive contrast (bright signal) on T1-weighted images</strong>. Gadolinium does <strong>not cross the intact blood-brain barrier (BBB)</strong>. Therefore, <strong>low-grade gliomas</strong> without BBB disruption do not enhance, whereas <strong>high-grade gliomas</strong> show contrast enhancement due to BBB breakdown.</li>\n<li><strong>Toxicity and Chelation:</strong> Free gadolinium is <strong>toxic</strong> and can cause <strong>multi-organ fibrosis</strong> if retained. To prevent this, gadolinium is always administered in a <strong>chelated form</strong>, commonly with DTPA (diethylenetriamine pentaacetic acid), and is excreted <strong>renally</strong>.</li>\n<li><strong>Contraindications and Pregnancy:</strong> Gadolinium is <strong>teratogenic</strong>, crosses the <strong>placental barrier</strong>, and is <strong>contraindicated in pregnancy</strong>. It should not be used unless absolutely necessary.</li>\n<li><strong>Adverse Effect &ndash; NSF:</strong> A major adverse effect of gadolinium is <strong>Nephrogenic Systemic Fibrosis (NSF)</strong>, which begins with <strong>skin fibrosis</strong> and can progress to <strong>multi-organ fibrosis</strong> and death.</li>\n<li><strong>Risk Factors for NSF:</strong> The risk of NSF is highest in patients with <strong>chronic kidney disease (CKD) stages 4 or 5</strong>, <strong>glomerular filtration rate (GFR) &lt; 30 mL/min</strong>, <strong>dialysis dependence</strong>, or <strong>acute kidney injury</strong>. Therefore, <strong>eGFR or serum creatinine</strong> must be evaluated before administering gadolinium to at-risk patients.</li>\n<li><strong>Gadolinium Risk Stratification:<br /> </strong>Low-risk agents include <strong>gadoteridol</strong> and <strong>gadobutrol</strong>.<br /> Intermediate-risk agents include <strong>gadobenate dimeglumine</strong> and <strong>gadoxetate disodium</strong> (also hepatocyte-specific).<br /> High-risk agents include <strong>gadodiamide</strong>, which should be avoided in vulnerable patients.</li>\n<li><strong>Breastfeeding:</strong> Gadolinium is considered safe during <strong>breastfeeding</strong>, and <strong>lactation should not be interrupted</strong> following its use.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Iodine (Option A):</strong> Iodine is a component of iodinated contrast media, which is associated with contrast-induced nephropathy, but not typically with nephrogenic systemic fibrosis.</p>\n<p><strong>DTPA (Option C):</strong> Diethylenetriaminepentaacetic acid (DTPA) is a chelating agent sometimes used in radiology (e.g., with Technetium-99m in renal scans) but is not typically associated with nephrogenic systemic fibrosis.</p>\n<p><strong>SF6 (Option D):</strong> Sulfur hexafluoride (SF6) is used as an ultrasound contrast agent and is not typically associated with nephrogenic systemic fibrosis.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Nephrogenic systemic fibrosis (NSF)</strong> is a serious adverse reaction that develops as a toxicity specifically to <strong>Gadolinium</strong>, primarily in patients with impaired kidney function.</p>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Barium Meal</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Barium Swallow</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Barium Meal Follow through</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Barium Enema</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the investigation done here?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202507214b601e6e-0dac-4ce0-bb11-ecd63e659195.png\"></span></p>",
      "unique_key": "DT1282926",
      "question_audio": null,
      "question_video": null,
      "map_id": 1282926,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\r\n<ul>\r\n<li><strong>Barium Meal Follow Through</strong> is a radiological study used for the assessment of the <strong>small intestinal loops, specifically the jejunum and ileum</strong>.</li>\r\n<li>In a Barium Meal Follow Through, the <strong>jejunum typically shows a \"feathery appearance\"</strong> due to the presence of valvulae conniventes (also known as plicae circularis).</li>\r\n<li>The <strong>ileum is described as \"featureless\"</strong> in such a study.</li>\r\n</ul>\r\n<p><strong>Comparison of Barium Studies</strong>&nbsp;</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202507216280a044-a931-4818-ab1a-4ea7ed299e52.png\">\r\n<p><strong>Contraindications of Barium Use:</strong></p>\r\n<ol>\r\n<li><strong>Suspected GI perforation</strong> (e.g., due to ulcer, trauma)<br /> &rarr; Use water-soluble contrast like <em>Gastrografin</em> instead.</li>\r\n<li><strong>High risk of aspiration</strong> (e.g., severe dysphagia or altered mental status)<br /> &rarr; Aspiration of barium can lead to chemical pneumonitis.</li>\r\n<li><strong>Post-operative or high-risk obstruction cases<br /> </strong>&rarr; May worsen obstruction or leak into the peritoneum.</li>\r\n<li><strong>Severe constipation or ileus<br /> </strong>&rarr; Risk of barium impaction.\r\n </li>\r\n</ol>\r\n<p>Barium Meal: <img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025072150a5b561-3ae3-4055-ad7f-ef2c3f97fef5.png\">\r\n </p>\r\n<p>Barium Swallow: <img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250721b34cf91b-f5c0-4bd3-bae2-d9d20cab3f59.png\">\r\n </p>\r\n<p>Barium Enema: <img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202507210ec29c97-886e-4880-b29a-71180ed20192.png\">\r\n </p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Different barium studies target different parts of the gastrointestinal tract. A <strong>Barium Meal Follow Through</strong> is specifically designed to visualize the <strong>jejunum and ileum</strong> (small bowel), identifiable by features like the feathery appearance of the jejunum.</p>",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Barium</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Gadolinium</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Telepaque</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Ioxaglate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which one of the following contrast agents is excreted in bile?</span></p>",
      "unique_key": "DT1282927",
      "question_audio": null,
      "question_video": null,
      "map_id": 1282927,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p><strong>Telepaque (iopanoic acid)</strong> is a water-soluble iodinated contrast agent historically used in <strong>oral cholecystography</strong>. It is <strong>absorbed from the gastrointestinal tract and excreted via the biliary system</strong>, allowing visualization of the gallbladder and biliary ducts. This excretion into bile makes it useful for assessing <strong>cystic duct patency</strong> and gallbladder function. Though now outdated and replaced by ultrasound, Telepaque remains a classic example of a biliary-excreted contrast agent.</p>\n<ul>\n<li>Iodine is <strong>radio-opaque</strong>, <strong>water-soluble</strong>, and suitable for <strong>intravascular contrast</strong>. These compounds are <strong>tri-iodinated benzene derivatives</strong>.</li>\n<li>Most <strong>water-soluble iodinated contrast agents</strong> are <strong>excreted renally</strong>, but some like <strong>Telepaque (iopanoic acid)</strong> or <strong>calcium iopodate</strong> undergo <strong>biliary excretion</strong>.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Barium (Option A):</strong> This statement is <strong>incorrect</strong> as the answer to the question. Barium sulfate is an insoluble contrast agent used for imaging the gastrointestinal (GI) tract (e.g., barium swallow, barium meal, barium enema). It passes through the GI tract and is excreted unchanged in feces, not in bile.</p>\n<p><strong>Gadolinium (Option B):</strong> This statement is <strong>incorrect</strong> as the answer to the question. Gadolinium-based contrast agents are paramagnetic agents used in Magnetic Resonance Imaging (MRI). They are primarily excreted by the kidneys through glomerular filtration, not in bile.</p>\n<p><strong>Ioxaglate (Option D):</strong> This statement is <strong>incorrect</strong> as the answer to the question. Ioxaglate is a water-soluble, iodinated contrast agent, typically used in angiography, urography, and CT imaging. Like most water-soluble iodinated contrast agents, it is predominantly excreted renally (by the kidneys) and not via the biliary system.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Among common contrast agents, <strong>Telepaque (iopanoic acid)</strong> is unique for its primary excretion via the <strong>biliary system</strong>, enabling imaging of the gallbladder and bile ducts.</p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">ioxaglate</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Diatrizoate</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">iohexol</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">iothalamate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is an ionic dimer?</span></p>",
      "unique_key": "DT1282928",
      "question_audio": null,
      "question_video": null,
      "map_id": 1282928,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p><strong>Ioxaglate</strong> is classified as an <strong>ionic dimer</strong> among the types of iodinated radiocontrast agents.</p>\n<ul>\n<li>Iodinated radiocontrast agents are broadly categorized based on their ionic properties and molecular structure (monomer vs. dimer).</li>\n<li><strong>Ionic Dimers</strong> specifically include <strong>ioxaglate</strong></li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025072101804dca-dc62-4db9-8d69-c7fabe345d8b.png\">\n<p><strong>Key Takeaway:</strong></p>\n<p>Iodinated radiocontrast agents are categorized by their ionic nature and molecular size. <strong>Ioxaglate</strong> is a key example of an <strong>ionic dimer</strong>, distinguishing it from ionic monomers (like Diatrizoate and Iothalamate) and non-ionic monomers (like Iohexol).</p>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">High Osmolar Agent</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Low Osmolar Agent</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Gadolinium-DTPA</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Thick barium sulphate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The contrast agent preferred for Tracheo-oesophagal fistula is?</span></p>",
      "unique_key": "DT1282929",
      "question_audio": null,
      "question_video": null,
      "map_id": 1282929,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation of Answer:</strong></p>\n<p>A <strong>water-soluble Low Osmolar Contrast Agent</strong>, such as <strong>IOHEXOL</strong>, is the <strong>preferred contrast agent</strong> in patients with a Tracheoesophageal Fistula.</p>\n<ul>\n<li>The use of a low osmolar agent is crucial because if the contrast agent enters the tracheobronchial tree through the fistula, it is <strong>less irritating to the airways</strong> and <strong>more rapidly absorbed</strong> than high osmolar agents or barium.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>High Osmolar Agent (Option A):</strong> High osmolar agents are <strong>not preferred</strong> for imaging tracheoesophageal fistula because they can cause <strong>significant pulmonary edema</strong> and inflammation if aspirated into the lungs.</p>\n<p><strong>Gadolinium-DTPA (Option C):</strong> Gadolinium-DTPA is a <strong>MRI contrast agent</strong> and is <strong>not typically used</strong> for fluoroscopic or CT evaluation of tracheoesophageal fistula.</p>\n<p><strong>Thick barium sulphate (Option D):</strong> Thick barium sulphate is <strong>contraindicated</strong> for suspected tracheoesophageal fistula due to the <strong>risk of severe pneumonitis</strong> if aspirated into the lungs.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>For diagnosing Tracheoesophageal Fistula, a <strong>water-soluble, low osmolar contrast agent like Iohexol is preferred</strong> due to its safety profile if aspirated, as opposed to high osmolar agents, gadolinium, or thick barium sulphate.</p>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}